ArticleVaccines2026

Cost-Effectiveness and Budget Impact Analysis of the Trivalent Adjuvanted Influenza Vaccine in People over 50 Years of Age for Argentina.

Leandro Javier Pastori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.